New data on ACS & TAVR | Improving the accuracy of near-infrared fluorescence imaging | NSAID use & T2D

“It is vital to identify patients who are at a high risk for ACS after TAVR for potential treatment beforehand,” according a new analysis published in the American Journal of Cardiology.

NIRF imaging could help interventional cardiologists personalize care in the cath lab, but a key engineering issue needed to be solved first.

The link between NSAIDs such as ibuprofen and heart failure was especially strong among patients 80 years old and older. For patients 65 years old and younger, on the other hand, no such link was identified. 

The STOP-CA trial showed that statins can help chemotherapy patients avoid potential side effects related to anthracycline agents. Co-principal investigators Marielle Scherrer-Crosbie, MD, and Tomas Neilan, MD, discussed the details of that trial at ACC.23. 

The news comes after Abbott had to recall more than 4.2 million older glucose monitoring systems due to issues with batteries overheating. 

A new JAMA Internal Medicine study suggests that communication coaching for cardiologists may help improve patient interactions by encouraging questions and increasing empathy.

Overall, cardiologists made corrections to 16.8% of AI-generated assessments and 27.2% of sonographer assessments.

Commissural alignment is especially important now, researchers explained, because TAVR is being recommended for younger patients with longer life expectancies. 

The acquisition is one of 2023's biggest healthcare deals so far.

Patients who have these pathways disconnected record marked seizure-free periods of time in the long-term, according to new research.